Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How does the microbiome factor into neurodegenerative diseases?
Related Questions
What would be your approach to the consideration of the use of antiamyloid monoclonal antibodies for nonamnestic Alzheimer's disease with a positive biomarker for brain amyloid pathology?
Is there sufficient evidence yet to support the use of lithium supplementation or prescription in the management of neurodegenerative diseases?
How do you counsel women post-natural menopause who are interested in HRT for reducing dementia risk?
Are there specific tools that you request for an IEP of a child with dyslexia?
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
How do you treat agitation in progressive supranuclear palsy?
How do you decide when to order blood-based biomarker testing for Alzheimer's disease and which one to choose?
How do you utilize FDG PET in the evaluation of dementias?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
When is it useful to test for multiple amyloid-related biomarkers for patients undergoing work-up for cognitive impairment?
